Table of Contents

2019-2024 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption 2014-2024
2.1.2 Nuclear Medicine/Radiopharmaceuticals Consumption CAGR by Region
2.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic
2.2.2 Therapeutic
2.3 Nuclear Medicine/Radiopharmaceuticals Consumption by Type
2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2014-2019)
2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
2.3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2014-2019)
2.4 Nuclear Medicine/Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.5 Nuclear Medicine/Radiopharmaceuticals Consumption by Application
2.5.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
2.5.2 Global Nuclear Medicine/Radiopharmaceuticals Value and Market Share by Application (2014-2019)
2.5.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Application (2014-2019)

3 Global Nuclear Medicine/Radiopharmaceuticals by Players
3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Players
3.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Players (2017-2019)
3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Players (2017-2019)
3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Players
3.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Players (2017-2019)
3.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Players (2017-2019)
3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Players
3.4 Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Nuclear Medicine/Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion

4 Nuclear Medicine/Radiopharmaceuticals by Regions
4.1 Nuclear Medicine/Radiopharmaceuticals by Regions
4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption by Regions
4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Value by Regions
4.2 Americas Nuclear Medicine/Radiopharmaceuticals Consumption Growth
4.3 APAC Nuclear Medicine/Radiopharmaceuticals Consumption Growth
4.4 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Growth
4.5 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Consumption Growth

5 Americas
5.1 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
5.1.1 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
5.1.2 Americas Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
5.2 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Type
5.3 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
6.1.1 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
6.1.2 APAC Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
6.2 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Type
6.3 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Countries
7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
7.2 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Type
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Countries
8.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
8.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Type
8.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Nuclear Medicine/Radiopharmaceuticals Distributors
10.3 Nuclear Medicine/Radiopharmaceuticals Customer

11 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast
11.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast (2019-2024)
11.2 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Regions
11.2.1 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Regions (2019-2024)
11.2.2 Global Nuclear Medicine/Radiopharmaceuticals Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Type
11.8 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Application

12 Key Players Analysis
12.1 China Isotope and Radiation
12.1.1 Company Details
12.1.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
12.1.3 China Isotope and Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 China Isotope and Radiation News
12.2 Dongcheng
12.2.1 Company Details
12.2.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
12.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Dongcheng News
12.3 Jaco
12.3.1 Company Details
12.3.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
12.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Jaco News
12.4 Ciaeriar
12.4.1 Company Details
12.4.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
12.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Ciaeriar News
12.5 Advanced Molecular-imaging Solution
12.5.1 Company Details
12.5.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Advanced Molecular-imaging Solution News
12.6 Shanghai Atom Kexing
12.6.1 Company Details
12.6.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
12.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Shanghai Atom Kexing News
...

13 Research Findings and Conclusion